AzTrials
AzTrials

AgingNCT01883271

Effect of Aerobic Interval Training on Cardiovascular Function in Aging

A study testing High intensity aerobic interval training and Continuous moderate intensity exercise in people with Aging, run by University of Florida at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Study objectives: 1. To compare cardiovascular function in older compared to young healthy adults. 2. To compare the effect of 8 weeks of aerobic interval training vs. continuous moderate exercise on cardiovascular function in healthy older adults. Hypotheses: 1. Read more about this study

Who is it for?
Ages 18 to 79 yearsHealthy volunteers can take part
Conditions the study is for
Aging
What is being tested?
High intensity aerobic interval training and Continuous moderate intensity exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
May 2013to 21 Feb 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 79 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy men and women 55 to 79 years of age
  • Sedentary or minimally physically active for at least the prior 1 year.
  • Women will be premenopausal or postmenopausal (either natural or surgical) defined as a cessation of menses for at least 2 years.
  • Premenopausal women will be eumenorrheic and will be studied during the early follicular phase (days 1 through 6) of the menstrual cycle.
  • Able to give consent.
  • Healthy men and women 18 to 35 years of age
Show all 9Show fewer
  • Sedentary or minimally physically active for at least the prior 1 year.
  • Women will be premenopausal, eumenorrheic and will be studied during the early follicular phase (days 1 through 6) of the menstrual cycle.
  • Able to give consent.

Who cannot join

  • history of diabetes
  • history of any relevant cardiovascular diseases (myocardial infarction, angina pectoris, history of coronary artery bypass surgery or angioplasty, congestive heart failure, or arrhythmia)
  • hypertension (≥160 mmHg systolic or ≥100 mmHg diastolic)
  • history of renal impairment
  • history of gout or hyperuricemia
  • history of hepatic disease or infection with hepatitis B, C
Show all 15Show fewer
  • history of seizures, or other relevant on-going or recurrent illness
  • recent (within 3 months) or recurrent hospitalizations
  • use of tobacco products
  • >5 % weight change in the prior 6 months.
  • current intake of medications that may affect study results
  • participation in regular aerobic exercise training (>30 minutes,
  • 3 times/wk in the past year).
  • premenopausal women taking oral contraceptives and postmenopausal women taking hormone replacement therapy.
  • pregnancy (positive urine pregnancy test) or lactation

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Florida

    Gainesville, Florida, 32611

Other trials in United States

About this study

Official title: Effect of Aerobic Interval vs. Continuous Exercise Training on Cardiovascular Function in Aging

Study objectives:

  1. To compare cardiovascular function in older compared to young healthy adults.
  2. To compare the effect of 8 weeks of aerobic interval training vs. continuous moderate exercise on cardiovascular function in healthy older adults.

Hypotheses:

  1. Compared to young adults, older adults will have lower cardiovascular function.
  2. Compared to continuous moderate intensity exercise training, interval training will be more effective in improving cardiovascular function in older adults.
Read the detailed description

Cardiovascular function will be measured at baseline in older healthy adults and young healthy controls. Older adults will be randomized to the aerobic interval training group, continuous moderate exercise group or non-exercise control group. At the end of the 8-week exercise intervention, baseline measures will be repeated in the older adults.

Conditions
Aging
Being tested
High intensity aerobic interval training, Continuous moderate intensity exercise

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High intensity aerobic interval trainingOther

    Supervised aerobic interval training will be performed on bicycles 4 times per week for 8 weeks. Each training session will last 40 minutes and will consist of 10-minute warm up at 70% of maximal heart rate (HRmax), four 4-minute intervals at 90% of HRmax with 3-min active recovery at 70% of HRmax and 5-minute cool down at 70% of HRmax.

  • Continuous moderate intensity exerciseOther

    Supervised exercise training will be performed on bicycles 4 times per week for 8 weeks. Each training session will last 47 minutes and will consist of continuous moderate intensity cycling at 70% of HRmax.

Study groups in NCT01883271
Study groupRoleWhat they receive
High intensity aerobic interval trainingExperimentalOlder adults will complete 8 weeks of high intensity aerobic interval exercise training.
Receives: Other: High intensity aerobic interval training
Continuous moderate intensity exerciseExperimentalOlder adults will complete 8 weeks of continuous moderate intensity exercise training.
Receives: Other: Continuous moderate intensity exercise
Non-exercise control groupNo interventionOlder adults assigned to the non-exercise control group will maintain their normal lifestyle for 8 weeks.
Young Healthy controlsNo interventionYoung healthy subjects will be assigned to the healthy control group and will undergo baseline measures only.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in vascular endothelial function

    Brachial flow-mediated dilation using ultrasonography

    Measured: At baseline and after 8 weeks of exercise training

Secondary outcomes (4)
  1. Change in factors related with endothelial function

    Blood and cellular markers of oxidative stress and inflammation

    Measured: At baseline and after 8 weeks of exercise training

  2. Change in arterial stiffness

    Arterial stiffness and wave reflection will be measured using the SphygmoCor device

    Measured: At baseline and after 8 weeks of exercise training

  3. Change in cardiac function

    Left ventricular systolic and diastolic function will be measured using echocardiography

    Measured: At baseline and after 8 weeks of exercise training

  4. Change in maximal oxygen consumption

    Maximal oxygen consumption will be measured using online computer-assisted open-circuit spirometry during incremental treadmill exercise

    Measured: At baseline and after 8 weeks of exercise training

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2013 (estimated)
  2. Study startMay 2013
  3. Primary completion21 Feb 2019
  4. Study completion21 Feb 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01883271
Sponsor's protocol ID
IRB201700044
Other IDs
551-2012
Status last verified
Feb 2019
First submitted
13 Jun 2013
Last updated
25 Feb 2019
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing High intensity aerobic interval training and Continuous moderate intensity exercise in people with Aging, run by University of Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in vascular endothelial function (time frame: At baseline and after 8 weeks of exercise training). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in